• Search

Insights

Why make the switch from animal cells to human iPSC-Derived Sensory Neurons?

Why make the switch from animal cells to human iPSC-Derived Sensory Neurons?

Millions of people around the world suffer from debilitating pain. However, with impressive advances being made in pain research and drug discovery efforts, researchers are continuing to delve deeper into the molecular pathways underpinning pain, to ultimately improve both the screening of drug candidates and the quality of life for people across the world.

Expert tips on culturing human iPSC-Derived Sensory Neurons to aid your research

Expert tips on culturing human iPSC-Derived Sensory Neurons to aid your research

Innovations in biotechnology and advances in stem cell biology are currently revolutionizing biomedical research and drug discovery. One exciting breakthrough has been the ability to produce sensory neurons from human induced pluripotent stem cells (hiPSCs) and culture them in vitro on multi-electrode array (MEA) systems, to advance pain research and the discovery of effective pain therapies.

How can human iPSC-Derived Sensory Neurons transform your pain research?

How can human iPSC-Derived Sensory Neurons transform your pain research?

Millions of people around the world suffer from debilitating pain, causing immense suffering and reducing their quality of life. With the economic costs of chronic pain estimated to be up to $635 billion each year in the US alone , it’s crucial for scientists to be able to fully understand the functionality of human sensory neurons and how they respond to potential new drugs. In the race to find effective treatments, scientists commonly study in vitro neuron cultures to characterize the molecular pathways underlying pain, which can help to identify therapeutic targets and quickly screen potential drug candidates.